Precision medicine: Clarity for the complexity of dementia

Brenna Cholerton, Eric B. Larson, Joseph F. Quinn, Cyrus P. Zabetian, Ignacio F. Mata, C. Dirk Keene, Margaret Flanagan, Paul K. Crane, Thomas J. Grabowski, Kathleen S. Montine, Thomas J. Montine

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.

Original languageEnglish (US)
Pages (from-to)500-506
Number of pages7
JournalAmerican Journal of Pathology
Issue number3
StatePublished - Mar 1 2016

Bibliographical note

Publisher Copyright:
© Copyright 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.


Dive into the research topics of 'Precision medicine: Clarity for the complexity of dementia'. Together they form a unique fingerprint.

Cite this